Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs
出版年份 2019 全文链接
标题
Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs
作者
关键词
-
出版物
Pharmaceutics
Volume 11, Issue 3, Pages 110
出版商
MDPI AG
发表日期
2019-03-08
DOI
10.3390/pharmaceutics11030110
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil® or Caelyx® in advanced ovarian cancer
- (2018) Shravanti Bhowmik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
- (2018) Evan C Chen et al. OncoTargets and Therapy
- Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
- (2018) Jimin Zhang et al. Frontiers in Microbiology
- FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
- (2018) Aviva C Krauss et al. CLINICAL CANCER RESEARCH
- Predicting drug delivery efficiency into tumor tissues through molecular simulation of transport in complex vascular networks
- (2018) Evan P. Troendle et al. JOURNAL OF CONTROLLED RELEASE
- Physiologically Based Pharmacokinetic Modeling of Nanoparticles
- (2018) Dongfen Yuan et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Overcoming key biological barriers to cancer drug delivery and efficacy
- (2017) Susy M. Kim et al. JOURNAL OF CONTROLLED RELEASE
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- Phase II study of marqibo in adult patients with refractory or relapsed philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL).
- (2017) S. M. O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
- (2016) Min Li et al. AAPS Journal
- Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
- (2016) Neil R. H. Stone et al. DRUGS
- Equivalency challenge: Evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model
- (2016) Judith A. Smith et al. GYNECOLOGIC ONCOLOGY
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
- (2015) T. C. Chang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
- (2015) HM Jones et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents
- (2015) Andrew T Lucas et al. Expert Opinion on Drug Metabolism & Toxicology
- Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
- (2015) Huali Wu et al. International Journal of Nanomedicine
- Improving drug delivery to solid tumors: Priming the tumor microenvironment
- (2015) Iftikhar Ali Khawar et al. JOURNAL OF CONTROLLED RELEASE
- The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation
- (2015) Shawn Stapleton et al. JOURNAL OF CONTROLLED RELEASE
- A Pharmacokinetic Model for Quantifying the Effect of Vascular Permeability on the Choice of Drug Carrier: A Framework for Personalized Nanomedicine
- (2015) Ameya R. Kirtane et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Computational Modeling of Tumor Response to Drug Release from Vasculature-Bound Nanoparticles
- (2015) Louis T. Curtis et al. PLoS One
- Physiologically Based Pharmacokinetic Modeling: From Regulatory Science to Regulatory Policy
- (2014) V Sinha et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
- (2014) Sihem Ait-Oudhia et al. Pharmaceutics
- Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors
- (2013) Huali Wu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Tumor perfusion imaging predicts the intra-tumoral accumulation of liposomes
- (2013) Shawn Stapleton et al. JOURNAL OF CONTROLLED RELEASE
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- The Utility of Modeling and Simulation in Drug Development and Regulatory Review
- (2013) Shiew-Mei Huang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Dual Physiologically Based Pharmacokinetic Model of Liposomal and Nonliposomal Amphotericin B Disposition
- (2013) Leonid Kagan et al. PHARMACEUTICAL RESEARCH
- A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature
- (2013) Hermann B. Frieboes et al. PLoS One
- A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors
- (2013) Shawn Stapleton et al. PLoS One
- Combining two strategies to improve perfusion and drug delivery in solid tumors
- (2013) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model
- (2012) Triantafyllos Stylianopoulos et al. ANNALS OF BIOMEDICAL ENGINEERING
- Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
- (2012) W. C. Zamboni et al. CLINICAL CANCER RESEARCH
- Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions
- (2012) P Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes
- (2012) Xiaoming Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Endocytosis and Intracellular Trafficking as Gateways for Nanomedicine Delivery: Opportunities and Challenges
- (2012) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
- (2011) Malcolm Rowland et al. Annual Review of Pharmacology and Toxicology
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
- (2011) Huali Wu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes
- (2011) B.J. Crielaard et al. JOURNAL OF CONTROLLED RELEASE
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Allometric scaling of pegylated liposomal anticancer drugs
- (2011) Whitney P. Caron et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- Physiologically Based Pharmacokinetic Modeling of Nanoparticles
- (2010) Mingguang Li et al. ACS Nano
- High-Dose Bupivacaine Remotely Loaded into Multivesicular Liposomes Demonstrates Slow Drug Release Without Systemic Toxic Plasma Concentrations After Subcutaneous Administration in Humans
- (2010) Elyad M. Davidson et al. ANESTHESIA AND ANALGESIA
- Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
- (2010) Rao N. V. S. Mamidi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
- (2010) P Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts
- (2010) Wah-Seng Lim et al. LEUKEMIA RESEARCH
- Mifamurtide
- (2010) James E. Frampton PEDIATRIC DRUGS
- Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma
- (2009) M. A. Rodriguez et al. CANCER
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
- (2009) Hemant Sarin et al. Journal of Translational Medicine
- Amphotericin B: side effects and toxicity
- (2009) Rafael Laniado-Laborín et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Epaxal®: a virosomal vaccine to prevent hepatitis A infection
- (2008) Patrick A Bovier Expert Review of Vaccines
- Multiscale modelling and nonlinear simulation of vascular tumour growth
- (2008) Paul Macklin et al. JOURNAL OF MATHEMATICAL BIOLOGY
- Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development
- (2008) Daryl C. Drummond et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started